Dayananda Kasala

477 citations
17 papers · 410 indexed · h-index 11
Topics
Virus-based gene therapy research (15 papers)RNA Interference and Gene Delivery (13 papers)CAR-T cell therapy research (6 papers)

In The Last Decade

Dayananda Kasala

17 papers receiving 408 citations

Peers

Dayananda Kasala
Comparison fields: 5 of 52
  • Molecular Biology 269
  • Genetics 265
  • Oncology 155
  • Biotechnology 90
  • Biomedical Engineering 47
Replace Joung-Woo Choi with:
Joung-Woo Choi South Korea
Joung-Woo Choi South Korea
Yusuke Eto Japan
Erlinda Quijano Germany
Pyung-Hwan Kim South Korea
Shinnosuke Kurachi Japan
Gaurav Backliwal Switzerland
Jere T. Pikkarainen Finland
Simon S. Briggs United Kingdom
Martin Bertschinger Switzerland
Dayananda Kasala relative to Joung-Woo Choi South Korea Joung-Woo Choi's profile →
Citations per field
00.5×1.5×2.0×
Joung-Woo Choi · 1×
Citations per year

Countries citing papers authored by Dayananda Kasala

Since Specialization
Citations

This map shows the geographic impact of Dayananda Kasala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dayananda Kasala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dayananda Kasala more than expected).

Fields of papers citing papers by Dayananda Kasala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dayananda Kasala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dayananda Kasala. The network helps show where Dayananda Kasala may publish in the future.

Co-authorship network of co-authors of Dayananda Kasala

This figure shows the co-authorship network connecting the top 25 collaborators of Dayananda Kasala. A scholar is included among the top collaborators of Dayananda Kasala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dayananda Kasala. Dayananda Kasala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 2
2 3
3 2
4 5
5 8
6 12
7 37
8 42
9 1
10 32
11 48
12 44
13 49
14 34
15 36
16 32
17 23

About Dayananda Kasala

Dayananda Kasala is a scholar working on Biotechnology, Genetics and Oncology, having authored 17 papers that have together received 410 indexed citations. Recurring topics across this work include Virus-based gene therapy research (15 papers), RNA Interference and Gene Delivery (13 papers) and CAR-T cell therapy research (6 papers). The work is most often cited by research in Biotechnology (90 citations), Genetics (265 citations) and Oncology (155 citations). Dayananda Kasala has collaborated with scholars based in South Korea, United States and Taiwan. Frequent co-authors include Chae‐Ok Yun, Sung Wan Kim, Joung-Woo Choi, JinWoo Hong, A‐Rum Yoon, Youjin Na, Soo‐Hwan Lee, Joung-Woo Choi, Sung Wan Kim and You Han Bae. Their work appears in journals such as Biomaterials, Chemical Engineering Journal and Journal of Controlled Release.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026